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determine under what circumstances sulfation of tyro- The TNF Receptor 1:
sine residues occurs in other antibodies, how it is regu- A Split Personality Complexlated, and to what extent it contributes to humoral im-
mune responses in immunologic disorders and to other
pathogens. In light of these results, there may also be
other naturally occurring posttranslational modifications The tumor necrosis factor receptor 1 (TNFR1), a proto-
that impact antibody specificity and/or affinity. typic member of the death receptor family signals both
Structural and mechanistic insights into HIV envelope cell survival and apoptosis. In this issue of Cell, Mi-
glycoprotein function have led to a deeper understand- cheau and Tschopp (2003) report that apoptotic TNFR1
ing of the obstacles to producing broadly neutralizing signaling proceeds via the sequential formation of two
antibodies. However, the findings of Choe et al. (2003) distinct complexes. Since the first complex can acti-
as well as new insights into the structural basis for HIV vate survival signals and influence the activity of the
neutralization by other mAbs (Calarese et al., 2003; second complex, this mechanism provides a check-
Saphire et al., 2001; Sharon et al., 2003) provide hope point to control the execution of apoptosis.
that some humoral responses can contain and/or pre-
vent HIV infection. Modified envelope proteins that ex- TNFR1 has pleiotropic activities such as induction of
pose cryptic epitopes, redirect immune responses to apoptosis and activation of the transcription factor
conserved sites, preserve the native oligomeric struc- NF-B, leading to the induction of a number of antiapo-
ture, and/or decrease entropic barriers are all possible ptotic proteins. Despite the extensive study of this re-
approaches and will need to be linked to a growing ceptor, the mechanism governing the decision to induce
understanding of the full conformational repertoire avail- one of these pathways over the other is very poorly
able to antibodies that can overcome steric and other understood. After the identification of the components
barriers. The challenges in this field remain great, but of the death inducing signaling complex (DISC) of the
the problems are at least better defined, and step- related death receptor CD95 (APO-1/Fas) (Peter and
pingstones for further investigation are clearly in place. Krammer, 2003), it was widely assumed that TNFR1
would also recruit the adaptor FADD and caspase-8
upon binding of the ligand TNF to initiate apoptosis.George Lin1 and James A. Hoxie
This model was supported by data from cells of FADDDepartment of Medicine
or caspase-8-deficient mice in which TNF-induced apo-Hematology-Oncology Division
ptosis was impaired (Varfolomeev et al., 1998, Yeh etUniversity of Pennsylvania
al., 1998). However, attempts to demonstrate a directPhiladelphia, Pennsylvania 19104
physical association of FADD and caspase-8 with
1Present address: Biological Mimetics, Inc., 124 Byte Drive, Freder- TNFR1 failed (Harper et al., 2003), while the antiapo-
ick, MD 21702
ptotic components of the signaling complex, TRAF-2,
TRADD, and c-IAP1 were readily detected (Shu et al.,Selected Reading
1996).
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formed (complex I) dissociates from TNFR1 and formsGerard, N.P., Gerard, C., Choe, H., and Sodroski, J. (2000). J. Biol.
Chem. 275, 33516–33521. a different complex in the cytosol (complex II), which
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teins such as FADD and assembles complex II. But whatWilson, I.A. (2001). Science 293, 1155–1159.
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Figure 1. Comparison of TNFR1 and CD95 Signaling
CD95 directly recruits FADD, procaspase-8, pro-caspase-10, and the caspase-8/10 regulator c-FLIP to the death-inducing signaling complex
(DISC) resulting in the release of active caspase-8 and -10, which in turn induce apoptosis, the default pathway for CD95. Alternatively, in
CD95 apoptosis-resistant cells, CD95 can also induce NF-B activation. In contrast, the TNFR1 default pathway activates NF-B and other
nonapoptotic pathways (not shown). This is mediated by the formation of complex I comprising TNFR1 and NF-B activating signaling
components such as RIP and TRAF2. This in turn results in transcriptional activation of a number of antiapoptotic genes such as c-FLIP and
others that prevent induction of apoptosis, in part by inhibition of caspase-8. After stimulation, some of the components of complex I are
posttranslationally modified (yellow circle; note: the nature and location of the modification is not yet known). This modification may serve as
a cue for the signaling components but not the receptor (not shown) to leave the plasma membrane and form complex II (an intracellular
DISC) by recruiting the apoptosis-inducing components FADD, procaspase-8, and either procaspase-10 (DISC on) or c-FLIP (DISC off). Dark
blue bold lines indicate the default pathways, which are survival for TNFR1 and apoptosis for CD95. Only the membrane proximal events of
apoptosis signaling are shown. IKKs, the IB kinase complex. Death domains are represented in red and death effector domains in blue.
weight of these signaling components would be consis- in the cytosol, or its association with the cytoskeleton,
an observation reported for other apoptotic proteinstent with mono and/or diubiquitination. Many compo-
nents of the apoptosis machinery including RIP and during the induction of apoptosis, may be facilitating
the recruitment of the caspases to the complex, poten-TNFR1 (Legler et al., 2003) have been shown to be ubi-
quitinated and monoubiquitination has been identified tially by bringing the complex in proximity to the apo-
ptotic proteins. Because the TNFR1 has been shown toas a regulatory modification in the context of apoptosis
signaling (Lee and Peter, 2003). It is tempting to specu- activate NF-B from within lipid rafts (Legler et al., 2003)
and internalizes following stimulation (Schutze et al.,late that this modification is responsible for the dissocia-
tion of complex I from the receptor. 1999), it cannot be excluded at this point that complex
I is localized in lipid rafts and complex II requires TNFR1The formation of complex II involves two molecules
related to caspase-8: the proapoptotic caspase-10 and to internalize. The work by Micheau and Tschopp has
now provided the basis to address these issues.the caspase regulator c-FLIPL. The authors suggest that
c-FLIPL, which is upregulated following activation of This study may also be relevant for our understanding
of the signaling mechanisms of other death receptorsNF-B, inhibits the apoptotic activity of complex II by
interfering with the activation of caspase-8. The authors such as CD95. Recruitment of FADD and caspase-8 to
the CD95 receptor is apparently direct, resulting in thesupport this model with the observation that in cells
protected from apoptosis through TNFR1, a relatively robust production of the death signal. However, it has
been reported that a subset of CD95 apoptosis sensitivehigh level of c-FLIPL is found in complex II, whereas in
cells engineered to be NF-B signaling deficient, c-FLIPL cells (type II cells) cannot recruit FADD and caspase-8
to the activated receptor reminiscent of the inability ofis not detected, allowing the activation of the death
pathway. In contrast, caspase-10 is found at high levels TNFR1 to directly recruit these apoptotic components
(Barnhart et al., 2003). It can now be determined if typein complex II of TNF apoptosis sensitive cells, whereas
in protected cells it is profoundly reduced. The two mole- II cells use similar mechanisms as TNFR1 to activate
caspase-8.cules appear to be mutually exclusive in complex II,
suggesting that caspase-10 interaction with caspase-8 The two-step model of TNFR1 apoptotic signaling also
explains the known delay of apoptosis induction in com-may be mediating the apoptotic response following the
formation of complex II. c-FLIPL would then be the arbi- parison to CD95. This delay gives the cell an opportunity
to produce antiapoptotic proteins such as c-FLIP byter of this activation, determining the ability of complex
II to functionally signal for apoptosis. Finally, it is possi- transcriptional upregulation and provides a checkpoint
in the decision between life and death. Although theble that the dissociation of complex II and its localization
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model is suggestive, it remains to be shown whether Biochemists and geneticists lust to discover new para-
digms of biological regulation. Both camps apply theirTRADD plays the role of a key regulator in this process.
trade in crafty ways aimed at dissecting uncharted path-This could be addressed by using TRADD mutants with
ways ranging from intracellular signaling to cell division,selective deletion of the FADD and RIP/TRAF2 binding
embryonic patterning, or even animal behavior. Mostsites. The role of other signals emanating from the
fun of all is the discovery of a “pioneer” protein that canTNFR1 in this process remains to be examined; for ex-
be assigned to a new chore. Landing on these pioneersample, the engagement of RAIDD/caspase-2 and the
used to be the norm, in each case offering the challengeactivation of the JNK and MAPK pathways by TNFR1
of bootstrapping one’s way from polymeric matter tohave not been placed in the context of these findings.
function. As our body of biological knowledge has blos-Additionally, the nature of the protein that is responsible
somed over the past 25 years, one of the best shortcutsfor the posttranslational modifications of the TNFR1 sig-
to understanding detailed biochemical function—werenaling components has not been addressed. Many
that not part of the fundamental assay being employed—pathological situations are characterized by an imbal-
has been the use of the classic BLAST search. If Xance between NF-B-regulated survival and caspase-
barked like Y, and if one had an inkling that Y might bemediated apoptosis signals. The identification of two
of canine ancestry, then dog chow would be includeddistinct complexes regulating these two processes
on the supplies budget of the next grant application.could now provide the means for their selective targeting
As our information base matures, fewer and fewerfor therapeutic purposes to treat diseases such as can-
times do we end up with a virgin pioneer. Instead, one ofcer and autoimmunity.
two things now happens. We may find that the putative
function of our “new” macromolecule has already been
Bryan C. Barnhart and Marcus E. Peter spoken for in some half-baked transient transfection
The Ben May Institute for Cancer Research assay, centered around some over-hyped field, spon-
University of Chicago sored by some top-down RFA, out of some “product-
924 East 57th Street seeking” NIH institute, responsive to some congres-
Chicago, Illinois 60637 sional muscle, being lobbied by some special interest
group, with the term “omics” almost always in close
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What is one to think when a long and arduous geneticLegler, D.F., Micheau, O., Doucey, M.A., Tschopp, J., and Bron, C.
(2003). Immunity 18, 655–664. screen or biochemical purification leads to a protein
firmly established to perform an entirely different func-Micheau, O., and Tschopp, J. (2003). Cell 114, this issue, 181–190.
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in the vertebrate eye. Lens crytallin proteins are relatedSchutze, S., Machleidt, T., Adam, D., Schwandner, R., Wiegmann,
K., Kruse, M.L., Heinrich, M., Wickel, M., and Kronke, M. (1999). J. to, or are one-and-the-same as, argininosuccinate lyase,
Biol. Chem. 274, 10203–10212. enolase, glutathione S-tranferase, and lactate dehydro-
Varfolomeev, E.E., Schuchmann, M., Luria, V., Chiannilkulchai, N., genase (Wistow and Piatigorsky, 1987). In this seminal
Beckmann, J.S., Mett, I.L., Rebrikov, D., Brodianski, V.M., Kemper, case, one can safely conclude that the crystallin proteins
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Zheng, Roeder, and Luo report in the current issue of
Cell (Zheng et al., 2003) the biochemical purification andGene Switching by Metabolic
characterization of a transcriptional coactivator com-Enzymes—How Did You Get plex that contains, as an essential component, the
enzyme glyceraldehyde-3-phosphate dehydrogenaseon the Invitation List?
(GAPDH). Is this a case of GAPDH acting out a surrogate
role totally independent of its job in intermediary metab-
olism, analogous to the lens crystallin proteins? Or is
Histone gene expression in mammalian cells is code- its presence telling us something more intriguing—that
pendent upon the Oct-1 transcription factor and its the role of GAPDH in gene activation is either dependent
cognate, OCA-S coactivator complex. Surprisingly, upon its catalytic function, or influenced by the meta-
GADPH plays an essential role in the OCA-S complex bolic state of the cell? If so, an understanding of the
and confers redox dependence upon the in vitro tran- traditional role of the enzyme might provide unantici-
pated insight into the process under study.scription of histone genes.
